bioRxivImmunology
TIM3 is a context-dependent co-regulator of cytotoxic T cell function
H. Alamir, C. W. C. Wong, A. Alsubaiti, G. L. Edmunds, T. Grant, S. Alsulaimani, J. Boyd, C. J. Holland, D. J. Morgan, A. M. Gallimore, C. Wuelfing
Abstract
TIM3 is a co-regulatory receptor that is highly expressed on multiple immune cell types, including on T cells after prolonged exposure to antigen. It marks functionally suppressed cytotoxic T lymphocytes (CTL) in the tumor microenvironment. However, it is unresolved whether TIM3 acts directly on suppressed CTL. Moreover, the nature of TIM3 ligands remains controversial. Paradoxically, TIM3 combines inhibitory function in vivo with costimulatory signaling capability in vitro. Here we have investigated TIM3 in the direct interaction of suppressed murine and human CTL with tumor target cell using spheroids. TIM3 directly inhibited the function of such CTL. TIM3 regulated the ability of suppressed CTL to polarize their cytoskeleton as a required step in cytolysis. Expression of CEACAM1 in cis, on the CTL, blocked TIM3 function, expression of CEACAM1 and galectin9 in trans, on the tumor target cells, enhanced TIM3 function. TIM3 only functioned as an inhibitory receptor on the spheroid-suppressed CTL, not on active CTL in a two-dimensional tissue culture model. These data suggest that TIM3 amplifies T cell function, serving as a co-inhibitory or co-stimulatory receptor depending on the functional context of the T cell it is expressed on.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interaction with tumor cell spheroids induces suppression in primary human cytotoxic T cells
Amal Alsubaiti, Hanin Alamir, … Christoph Wülfing·Immunotherapy AdvancesPeer-reviewed·Dec 30, 2024
- The adenosine 2a receptor and TIM3 directly inhibit killing of tumor cells by cytotoxic T lymphocytes through interference with cytoskeletal polarization
G. L. Edmunds, C. W. L. Wong, … D. J. Morgan·bioRxiv·May 20, 2021
- Expression of Tim-3 drives naive Treg to an effector-like state with enhanced suppressive activity
H. Banerjee, H. Nieves-Rosado, … L. P. Kane·bioRxiv·Jul 31, 2020
- IL-3-driven T cell-basophil crosstalk enhances anti-tumor immunity
J. Wei, C. L. Mayberry, … C.-H. CHANG·Cancer Immunology ResearchPeer-reviewed·May 10, 2024
- Steroid Receptor Coactivator-3 is a Key Modulator of Regulatory T Cell-Mediated Tumor Evasion
S. J. Han, P. Jain, … B. W. O'Malley·bioRxiv·Mar 28, 2023
- Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors
A. Schietinger, G. Espinosa-Carrasco, … M. Hellmann·bioRxiv·Jul 3, 2023